ANTI-IGE THERAPY FOR SEVERE ASTHMA IN CHILDREN: TWO-YEAR TRIAL

The article summarizes a two-year experience of treating children and adolescents with severe uncontrolled atopic asthma using Omalizumab. This treatment facilitated to achieve full asthma control in 70% of patients and partial control in 30% of patients. Anti-Ig Etherapy contributes to reduce the f...

Full description

Bibliographic Details
Main Authors: T.Yu. Kulichenko, L.S. Namazova-Baranova, R.M. Torshkhoeva, O.F. Lukina, E.A. Vishneva
Format: Article
Language:English
Published: Paediatrician Publishers, LLC 2010-05-01
Series:Pediatričeskaâ Farmakologiâ
Online Access:https://pf.spr-journal.ru/jour/article/view/1146